Related Experiment Video
Updated: May 29, 2026
07:57
Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
Published on: January 20, 2023
[Heat shock protein 90--modulator of TNFalpha-induced apoptosis of Jurkat tumor cells]
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
|September 29, 2011
Abstract:
rTNFalpha-induced programmed death of Jurkat tumor cells cultured with 17-AAG, a selective inhibitor of heat shock protein (Hsp90), was studied by fluorescent microscopy with the use of FITC-labeled annexin V and propidium iodide. Caspase-3 and -8 activities were determined by spectrophotometry using a caspase- 3 and -8 colorimetric assay kit. It was shown that inhibition of Hsp90 leads to activation of Jurkat cell apoptosis while Hsp90 itself suppresses this process. 17-AAG enhances rTNFa-induced apoptosis of tumor cells.
Insights
Heat shock protein 90 (Hsp90) inhibition activates tumor cell apoptosis, while Hsp90 suppresses it. 17-AAG, an Hsp90 inhibitor, enhances tumor necrosis factor alpha (TNFa)-induced cancer cell death.
Area of Science:
- Molecular biology
- Cancer research
- Cellular signaling
Context:
- Heat shock protein 90 (Hsp90) is a crucial molecular chaperone involved in cancer cell survival and proliferation.
- Tumor necrosis factor alpha (TNFa) is a cytokine that can induce apoptosis in cancer cells.
- 17-AAG is a potent inhibitor of Hsp90 activity.
Purpose:
- To investigate the role of Hsp90 in regulating tumor necrosis factor alpha (TNFa)-induced apoptosis in Jurkat tumor cells.
- To determine the effect of Hsp90 inhibition by 17-AAG on TNFa-induced programmed cell death.
Summary:
- Jurkat tumor cells were treated with TNFa and 17-AAG, an Hsp90 inhibitor.
- Apoptosis was assessed using Annexin V/propidium iodide staining and caspase activity assays.
- Results indicate that Hsp90 inhibition by 17-AAG promotes Jurkat cell apoptosis, whereas Hsp90 itself appears to suppress this process.
- 17-AAG was found to enhance TNFa-induced apoptosis in these tumor cells.
Impact:
- This study elucidates a novel mechanism by which Hsp90 regulates cancer cell apoptosis.
- Targeting Hsp90 with inhibitors like 17-AAG may represent a promising therapeutic strategy to enhance the efficacy of TNFa-based cancer treatments.
- Findings contribute to understanding the complex interplay between Hsp90, TNFa signaling, and programmed cell death in cancer.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:31Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...